Evaluation Of Iodine-125 Interstitial Brachytherapy Using Micro-Positron Emission Tomography/Computed Tomography With F-18-Fluorodeoxyglucose In Hepatocellular Carcinoma Hepg2 Xenografts

Jun Zhang

DOI: https://doi.org/10.12659/MSM.912590

2019-01-01

Medical Science Monitor

Abstract:Background: Iodine-125 interstitial brachytherapy (I-125-IBT) is a promising treatment option for unresectable hepatocellular carcinoma (HCC). This study evaluated the usefulness of micro-positron emission tomography/computed tomography (micro-PET/CT) with F-18-fluorodeoxyglucose (F-18-FDG) in assessing response to I-121-IBT in HCC HepG2 xenograft.Material/Methods: Twelve mice with bilateral HepG2 xenografts were divided into 3 equal groups implanted with iodine-125 seeds into the left xenografts with a dose of 30, 50, and 80 Gy, respectively, and the right xenografts were used as internal controls. Before and 28 days after treatment, the F-18-FDG micro-PET/CT was performed. The ratios of left to right xenografts of tumor volume (R-IV), maximum standardized uptake value (R-SUVmax), mean optical density of caspase-3 expression (RMODcaspase-3), and apoptosis index (R-AI) were compared.Results: The R-TV means of the 50 and 80 Gy groups were significantly lower than in the 30 Gy group after treatment (P<0.01) and the R-TV means after treatment were lower than baseline in the 50 and 80 Gy groups (P<0.05). The R-SUVmax mean after treatment was lower than baseline in the 80 Gy group (P<0.05). The RMODcaspase-3 and R-AI, means of the 80 Gy group were higher than in the 30 Gy group (P<0.05). The R-SUVmax was correlated negatively RMODcaspase-3 (r=-0.624, P<0.05) and R-AI (r=-0.651, P<0.05).Conclusions: This study suggest that I-125-IBT inhibits tumor growth via upregulating caspase-3 expression and prompting apoptosis in HCC HepG2 xenografts. The F-18-FDG micro-PET/CT may be a useful functional imaging modality to assess early response to I-125-IBT in HCC HepG2 xenograft.